vs
Side-by-side financial comparison of FTC Solar, Inc. (FTCI) and LIFECORE BIOMEDICAL, INC. \DE\ (LFCR). Click either name above to swap in a different company.
FTC Solar, Inc. is the larger business by last-quarter revenue ($32.9M vs $31.1M, roughly 1.1× LIFECORE BIOMEDICAL, INC. \DE\). LIFECORE BIOMEDICAL, INC. \DE\ runs the higher net margin — -32.1% vs -110.7%, a 78.6% gap on every dollar of revenue. On growth, FTC Solar, Inc. posted the faster year-over-year revenue change (148.9% vs -4.5%). LIFECORE BIOMEDICAL, INC. \DE\ produced more free cash flow last quarter ($25.0K vs $-8.4M). Over the past eight quarters, FTC Solar, Inc.'s revenue compounded faster (61.6% CAGR vs -0.1%).
FTC Solar, Inc. is a leading global provider of advanced solar tracker systems, associated components, and supporting software for solar projects. It serves utility-scale, commercial, and industrial solar segments across key global markets, helping customers boost energy generation efficiency and lower overall project costs.
LIFECORE BIOMEDICAL, INC. is a biomedical firm focused on developing and manufacturing high-quality hyaluronic acid-based biomaterials. It operates three core segments: medical application products, pharmaceutical solutions, and personal care ingredients, with main markets spanning North America, Europe and the Asia-Pacific, supplying to leading medical device, pharmaceutical and cosmetic brand partners.
FTCI vs LFCR — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $32.9M | $31.1M |
| Net Profit | $-36.4M | $-10.0M |
| Gross Margin | 14.9% | 25.0% |
| Operating Margin | -17.2% | -9.9% |
| Net Margin | -110.7% | -32.1% |
| Revenue YoY | 148.9% | -4.5% |
| Net Profit YoY | -197.4% | -52.0% |
| EPS (diluted) | $-2.31 | $-0.29 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $32.9M | — | ||
| Q3 25 | $26.0M | $31.1M | ||
| Q2 25 | $20.0M | — | ||
| Q1 25 | $20.8M | $35.2M | ||
| Q4 24 | $13.2M | $32.6M | ||
| Q3 24 | $10.1M | $24.7M | ||
| Q2 24 | $11.4M | — | ||
| Q1 24 | $12.6M | $35.7M |
| Q4 25 | $-36.4M | — | ||
| Q3 25 | $-23.9M | $-10.0M | ||
| Q2 25 | $-15.4M | — | ||
| Q1 25 | $-3.8M | $-14.8M | ||
| Q4 24 | $-12.2M | $-6.6M | ||
| Q3 24 | $-15.4M | $-16.2M | ||
| Q2 24 | $-12.2M | — | ||
| Q1 24 | $-8.8M | $15.6M |
| Q4 25 | 14.9% | — | ||
| Q3 25 | 6.1% | 25.0% | ||
| Q2 25 | -19.6% | — | ||
| Q1 25 | -16.6% | 28.0% | ||
| Q4 24 | -29.1% | 34.0% | ||
| Q3 24 | -42.5% | 21.8% | ||
| Q2 24 | -20.5% | — | ||
| Q1 24 | -16.7% | 33.3% |
| Q4 25 | -17.2% | — | ||
| Q3 25 | -29.6% | -9.9% | ||
| Q2 25 | -57.5% | — | ||
| Q1 25 | -50.8% | -25.7% | ||
| Q4 24 | -101.7% | -6.0% | ||
| Q3 24 | -147.8% | -46.9% | ||
| Q2 24 | -104.3% | — | ||
| Q1 24 | -99.3% | -2.5% |
| Q4 25 | -110.7% | — | ||
| Q3 25 | -92.0% | -32.1% | ||
| Q2 25 | -77.2% | — | ||
| Q1 25 | -18.4% | -42.0% | ||
| Q4 24 | -92.7% | -20.2% | ||
| Q3 24 | -151.5% | -65.7% | ||
| Q2 24 | -107.1% | — | ||
| Q1 24 | -69.7% | 43.8% |
| Q4 25 | $-2.31 | — | ||
| Q3 25 | $-1.61 | $-0.29 | ||
| Q2 25 | $-1.18 | — | ||
| Q1 25 | $-0.58 | $-0.47 | ||
| Q4 24 | $-0.95 | $-0.25 | ||
| Q3 24 | $-1.21 | $-0.53 | ||
| Q2 24 | $-0.97 | — | ||
| Q1 24 | $-0.70 | $0.42 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $21.1M | $18.9M |
| Total DebtLower is stronger | $9.9M | $136.0M |
| Stockholders' EquityBook value | $-43.0M | $-10.5M |
| Total Assets | $111.8M | $235.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $21.1M | — | ||
| Q3 25 | $24.4M | $18.9M | ||
| Q2 25 | $3.5M | — | ||
| Q1 25 | $5.9M | $5.4M | ||
| Q4 24 | $11.2M | $9.5M | ||
| Q3 24 | $8.3M | — | ||
| Q2 24 | $10.8M | — | ||
| Q1 24 | $14.0M | — |
| Q4 25 | $9.9M | — | ||
| Q3 25 | $16.6M | $136.0M | ||
| Q2 25 | $10.9M | — | ||
| Q1 25 | $10.2M | $124.9M | ||
| Q4 24 | $9.5M | $111.3M | ||
| Q3 24 | — | $106.3M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $97.1M |
| Q4 25 | $-43.0M | — | ||
| Q3 25 | $-13.7M | $-10.5M | ||
| Q2 25 | $9.0M | — | ||
| Q1 25 | $15.5M | $2.2M | ||
| Q4 24 | $19.0M | $15.4M | ||
| Q3 24 | $30.4M | $-3.9M | ||
| Q2 24 | $44.2M | — | ||
| Q1 24 | $55.2M | $17.7M |
| Q4 25 | $111.8M | — | ||
| Q3 25 | $111.5M | $235.2M | ||
| Q2 25 | $83.0M | — | ||
| Q1 25 | $84.1M | $237.7M | ||
| Q4 24 | $89.9M | $255.4M | ||
| Q3 24 | $91.7M | $246.8M | ||
| Q2 24 | $100.3M | — | ||
| Q1 24 | $115.0M | $246.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 1.20× | — | ||
| Q1 25 | 0.65× | 56.05× | ||
| Q4 24 | 0.50× | 7.20× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 5.49× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-8.0M | $1.8M |
| Free Cash FlowOCF − Capex | $-8.4M | $25.0K |
| FCF MarginFCF / Revenue | -25.7% | 0.1% |
| Capex IntensityCapex / Revenue | 1.3% | 5.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-34.6M | $-16.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-8.0M | — | ||
| Q3 25 | $-14.6M | $1.8M | ||
| Q2 25 | $-2.3M | — | ||
| Q1 25 | $-8.5M | $1.2M | ||
| Q4 24 | $-16.7M | $-6.1M | ||
| Q3 24 | $-2.4M | $-613.0K | ||
| Q2 24 | $-3.8M | — | ||
| Q1 24 | $-11.9M | $-1.4M |
| Q4 25 | $-8.4M | — | ||
| Q3 25 | $-15.1M | $25.0K | ||
| Q2 25 | $-2.5M | — | ||
| Q1 25 | $-8.6M | $-4.3M | ||
| Q4 24 | $-17.0M | $-8.6M | ||
| Q3 24 | $-2.6M | $-4.0M | ||
| Q2 24 | $-4.5M | — | ||
| Q1 24 | $-12.3M | $-7.8M |
| Q4 25 | -25.7% | — | ||
| Q3 25 | -57.9% | 0.1% | ||
| Q2 25 | -12.4% | — | ||
| Q1 25 | -41.2% | -12.1% | ||
| Q4 24 | -128.6% | -26.3% | ||
| Q3 24 | -25.6% | -16.3% | ||
| Q2 24 | -39.2% | — | ||
| Q1 24 | -97.6% | -21.8% |
| Q4 25 | 1.3% | — | ||
| Q3 25 | 1.7% | 5.6% | ||
| Q2 25 | 0.9% | — | ||
| Q1 25 | 0.4% | 15.5% | ||
| Q4 24 | 2.2% | 7.5% | ||
| Q3 24 | 2.2% | 13.9% | ||
| Q2 24 | 6.1% | — | ||
| Q1 24 | 3.4% | 17.8% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -0.09× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FTCI
| Products | $26.2M | 80% |
| Services | $6.7M | 20% |
LFCR
| Transferred At Point In Time | $26.6M | 85% |
| Transferred Over Time | $4.5M | 15% |
